Market Tracker

05/02 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

5.32
Delayed Data
As of 3:59pm ET
 +0.08 / +1.53%
Today’s Change
4.08
Today|||52-Week Range
15.01
-36.59%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close5.24
Today’s open5.30
Day’s range5.07 - 5.33
Volume5,167,311
Average volume (3 months)6,990,196
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-45.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.30+2.84%
FPRXFive Prime Therapeut...+0.90+1.89%
RDUSRadius Health Inc+1.04+2.92%
AXONAxovant Sciences Ltd+1.13+8.69%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts